While these in vitro studies show several important aspects of ARMC4’s regulatory ability, we wished to further validate ARMC4’s role in a more clinically relevant sense by looking at tumor formation ability with high ARMC4 expression or shARMC4 knockdown in vivo. Here, ODAD2 is linked to neoplasm.